metformin has been researched along with concanavalin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arsenijevic, N; Jakovljevic, V; Lukic, ML; Micic, D; Milovanovic, M; Misirkic, M; Paunovic, V; Simovic Markovic, B; Stojanovic, M; Trajkovic, V; Volarevic, V; Vucicevic, L | 1 |
| Fan, W; Kang, X; Liu, H; Liu, Q; Luo, X; Tian, H; Yang, H; Yang, X | 1 |
2 other study(ies) available for metformin and concanavalin a
| Article | Year |
|---|---|
Metformin aggravates immune-mediated liver injury in mice.
Topics: Animals; Apoptosis; Autophagy; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokines; Flow Cytometry; Hepatocytes; Hypoglycemic Agents; Liver; Male; Metformin; Mice, Inbred BALB C; Mice, Inbred C57BL; Real-Time Polymerase Chain Reaction; T-Lymphocytes | 2015 |
[Metformin activates AMPK to alleviate acute fulminant hepatitis induced by concanavalin A in mice].
Topics: AMP-Activated Protein Kinases; Animals; Concanavalin A; Interleukin-6; Liver; Massive Hepatic Necrosis; Metformin; Mice; Tumor Necrosis Factor-alpha | 2022 |